Strengths

Current ratio of 2.27 and quick ratio of 1.99 indicate solid near-term liquidity.

Cash per share of 3.10 exceeds book value per share of 3.55 only modestly, supporting a reasonable balance sheet.

Net debt to EBITDA is low at 0.13, suggesting limited leverage risk.

Weaknesses

TTM gross margin is -319.3% and operating margin is -33.3%, showing severe operating inefficiency.

Return on equity of -160.3% and return on invested capital of -171.9% remain deeply negative.

Operating cash flow and free cash flow are both negative, with free cash flow per share at -8.44.

Opportunities

A low enterprise value of 3.06M and price-to-book of 1.01 may offer upside if execution improves.

Net current asset value of 1.24M and tangible book value per share of 3.51 provide some asset backing.

High R&D intensity at 19.9% of revenue could support future pipeline or product development if monetized effectively.

Threats

Revenue per share of 0.28 versus net income per share of -9.55 highlights a large earnings gap.

Days of sales outstanding at 218.6 and cash conversion cycle at 228.5 indicate slow working-capital conversion.

Interest coverage of -57.3 and debt service coverage of -53.2 signal ongoing financial stress if losses persist.

Overall Score